Yiheng Capital Management, L.P. Akero Therapeutics, Inc. Call Options Transaction History

Yiheng Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$37.27 - $50.24 $6.06 Million - $8.17 Million	-162,700 Reduced 49.83%	163,800 $6.27 Million
Q4 2022 Feb 14, 2023	BUY	$33.44 - $54.8 $8.38 Million - $13.7 Million	250,700 Added 330.74%	326,500 $17.9 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $769,370 - $2.58 Million	75,800 New	75,800 $2.58 Million

168

72.7M

178K

164K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.31B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Yiheng Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Yiheng Capital Management, L.P. with notifications on news.